A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors Meeting Abstract


Authors: Hammers, H.; Choueiri, T.; Plimack, E.; Rini, B.; Motzer, R.; Yin, L.; Perini, R.; Willemann-Rogerio, J.; Albiges, L.
Abstract Title: A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263501353
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-CT243
Notes: Meeting Abstract: CT243 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer